Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity

Add time:07/22/2019    Source:sciencedirect.com

A small library of novel copper and zinc imidazo[1,2-a]pyridine complexes have been synthesized. Their structures were confirmed by X-ray diffraction crystallography and a selection of these compounds was tested against five cancer cell lines originating from breast cancer (MCF-7 and MDA-MB-231), leukemia (K562 and HL-60) and colorectal cancer (HT-29). The imidazo[1,2-a]pyridines and their zinc complexes showed poor anticancer activity, while the copper complexes were active against the cancer cell lines with IC50 values comparable to and lower than camptothecin. For example, copper 6-bromo-N-cyclohexyl-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amine acetate 21 had an IC50 value lower than 1 μM against the HT-29 cells. Fluorescence microscopy with acridine orange, Hoechst 33342 and ethidium bromide, used in a preliminary investigation to evaluate morphological changes showed that copper 6-bromo-N-cyclohexyl-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amine acetate 21 caused both apoptosis, necrosis and paraptosis in the MCF-7 and HL-60 cells. A select group of copper N-cyclohexyl-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amines (26, 27, 29 and 31) induced apoptosis, paraptosis and deformed nuclei in MCF-7 cells.

We also recommend Trading Suppliers and Manufacturers of (6-BROMO-PYRIDIN-2-YL)-ACETONITRILE (cas 112575-11-8). Pls Click Website Link as below: cas 112575-11-8 suppliers

Prev:A randomized trial of Ecadotril (cas 112573-73-6) versus placebo in patients with mild to moderate heart failure: The U.S. Ecadotril (cas 112573-73-6) Pilot Safety Study
Next:4-Dimethylaminopyridinium derivatives of 1,2-dibromo-1,1,2,2-tetrafluoroethane: molecular structure of 1-(4-dimethylaminopyridinium)-2-bromo-1,1,2,2-tetrafluoroethane bromide and 1-(4-dimethylamino-pyridinium)-1,1,2,2-tetrafluoroethane bromide1)